Brand Drug Shortages Complicate US FDA Messaging To Congress

 
• By Michael McCaughan
  
Adderall
Califf answered questions from members of Congress about patients' difficulties obtaining Adderall for ADHD. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Generics

More from Biosimilars & Generics